Kelloggs Special K Cereal Recall Issued Over Glass Fragments
About 36,000 boxes of Kellogg’s Special K Red Berries Cereal have been recalled, due to the risk that there may be small glass fragments in the cereal, which could pose a serious risk of mouth and digestive system injuries for consumers.
The Kellogg’s Special K recall was announced on February 15, after Kellogg Company learned that glass fragments may have contaminated the cereal during the manufacturing process. While no injuries have been reported to date, consumers are being asked to not eat the cereal.
The recall consists of Kellogg Company Special K Red Berries cereal sold in 3 different sizes across the United States with the following UPC Code and “Best Used By” dates:
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
- 11.2 ounce packages, UPC code 3800059923 with a Better if Used Before Date of DEC 02 2013 followed by KNC 105 with a time stamp of 00:13-2:30
- 22.4 ounce packages, UPC code 3800078356 with a Better if Used Before Date of NOV 30 2013 followed by KNA 105 with a time stamp of 07:00-08:51 and a Better if Used Before Date of NOV 30 2013 followed by KNB 105 with a time stamp of 15:00-17:05
- 37 ounce packages, UPC code 3800020940 with a Better if Used Before Date of NOV 30 2013 followed by KNB 107 with a time stamp of 17:31-20:05
The Kellogg’s Special K Cereal products sold in sizes other than 11.2, 22.4 or 37 ounces are not being recalled and are not suspected to have glass fragments within.
This recall comes just a few months after a Kellogg Mini-Wheats recall was issued in October 2012, after the discovery of fragments of flexible metal mesh that came from a faulty manufacturing part.
Kellogg’s is advising consumers to check their cereal boxes to verify if it has been recalled and to contact Kellogg’s Consumer Affairs at 1-800-962-1413 or email them by visiting http://www.kelloggs.com/en_US/contact-us.html
"*" indicates required fields
More Top Stories
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.
A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.